PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Nov 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-11-01

Reporting Person: UECKER DARRIN (Director, Chief Technology Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-01	Stock Option (right to buy)	$4.38	A	330000	Acquired	2033-11-01	Common Stock (330000)	Direct

Footnotes

F1: 100% vesting upon the earlier of (i) the six (6) year anniversary of the grant date, and (ii) the 1-year anniversary of a Company change of control.